79.91
0.38%
+0.30
시간 외 거래:
79.75
-0.16
-0.20%
전일 마감가:
$79.61
열려 있는:
$78.13
하루 거래량:
1.77M
시가총액:
$8.81B
수익:
-
순이익/손실:
$-93.72M
주가수익비율:
-85.92
EPS:
-0.93
순현금흐름:
$-54.87M
1주 성능:
+4.55%
1개월 성능:
+5.31%
6개월 성능:
+691.97%
1년 성능:
+249.56%
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
12340 El Camino Real, Suite 250, San Diego, CA
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-05-31 | 재개 | ROTH MKM | Buy |
2023-03-28 | 재확인 | Maxim Group | Buy |
2023-03-17 | 개시 | Stifel | Buy |
2021-07-29 | 재개 | BTIG Research | Buy |
2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2020-06-05 | 개시 | BMO Capital Markets | Outperform |
2020-05-05 | 개시 | Chardan Capital Markets | Buy |
2020-05-01 | 개시 | BTIG Research | Buy |
2019-07-16 | 개시 | Oppenheimer | Outperform |
2019-06-25 | 개시 | Stifel | Buy |
2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2019-03-14 | 재확인 | Maxim Group | Buy |
2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
2018-12-12 | 개시 | B. Riley FBR | Buy |
2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2018-09-18 | 재확인 | H.C. Wainwright | Buy |
2018-09-18 | 재확인 | Maxim Group | Buy |
2018-09-18 | 재확인 | Raymond James | Outperform |
2018-07-20 | 개시 | SunTrust | Buy |
2018-06-28 | 개시 | Raymond James | Outperform |
2018-06-01 | 재확인 | Laidlaw | Buy |
2018-05-31 | 재확인 | Maxim Group | Buy |
2018-03-26 | 재개 | H.C. Wainwright | Buy |
2017-11-28 | 재확인 | Maxim Group | Buy |
2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks Investment Research
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
The Motley Fool
Is Viking Therapeutics Incredibly Undervalued?
The Motley Fool
Can This High-Flying Stock 10x in 10 Years?
The Motley Fool
1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst
The Motley Fool
3 Millionaire-Maker Biotech Stocks
The Motley Fool
Viking Therapeutics Inc (VKTX) 재무 분석
Viking Therapeutics Inc (VKTX) 순이익 2024
VKTX은 2024-03-31 종료 분기에 대해 순이익(지난 12개월)이 -93.72M 달러로 보고했으며, 전년대비 -29.64% 감소했습니다.
Viking Therapeutics Inc (VKTX) 현금흐름 2024
2024-03-31 종료 분기에 VKTX은 현금흐름(지난 12개월)으로 -54.87M 달러를 기록했으며, 전년 대비 +12.23% 증가했습니다.
Viking Therapeutics Inc (VKTX) 주당 순이익 2024
VKTX이 보고한 2024-03-31 종료 분기의 주당 순이익(지난 12개월)은 -0.93달러이며, 전년 대비 +2.11% 성장했습니다.
Viking Therapeutics Inc 주식 (VKTX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
ZANTE GREG | Chief Financial Officer |
May 03 '24 |
Sale |
74.69 |
66,756 |
4,986,008 |
174,854 |
Mancini Marianna | Chief Operating Officer |
May 01 '24 |
Option Exercise |
6.18 |
281,425 |
1,740,575 |
629,933 |
Mancini Marianna | Chief Operating Officer |
May 01 '24 |
Sale |
78.66 |
281,425 |
22,136,474 |
348,508 |
Lian Brian | President & CEO |
Feb 09 '24 |
Sale |
29.90 |
45,000 |
1,345,500 |
2,139,882 |
Lian Brian | President & CEO |
Feb 08 '24 |
Option Exercise |
3.76 |
189,079 |
711,367 |
2,404,882 |
Rouan Sarah Kathryn | Director |
Feb 08 '24 |
Option Exercise |
8.32 |
25,000 |
208,000 |
25,000 |
Lian Brian | President & CEO |
Feb 08 '24 |
Sale |
26.87 |
269,079 |
7,230,784 |
2,184,882 |
Rouan Sarah Kathryn | Director |
Feb 08 '24 |
Sale |
28.05 |
25,000 |
701,250 |
0 |
Lian Brian | President & CEO |
Jan 31 '24 |
Option Exercise |
1.23 |
85,000 |
104,550 |
2,349,882 |
Lian Brian | President & CEO |
Jan 31 '24 |
Sale |
24.71 |
85,000 |
2,100,750 |
2,264,882 |
자본화:
|
볼륨(24시간):